- Home
- NCRA vs EDSA Comparison
NCRA vs EDSA Comparison
Compare NCRA & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- EDSA
- Stock Information
- Founded
- NCRA 2002
- EDSA 2015
- Country
- NCRA Taiwan
- EDSA Canada
- Employees
- NCRA N/A
- EDSA N/A
- Industry
- NCRA Farming/Seeds/Milling
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- EDSA Health Care
- Exchange
- NCRA Nasdaq
- EDSA Nasdaq
- Market Cap
- NCRA 14.7M
- EDSA 13.8M
- IPO Year
- NCRA N/A
- EDSA N/A
- Fundamental
- Price
- NCRA $1.02
- EDSA $2.08
- Analyst Decision
- NCRA
- EDSA Strong Buy
- Analyst Count
- NCRA 0
- EDSA 2
- Target Price
- NCRA N/A
- EDSA $13.00
- AVG Volume (30 Days)
- NCRA 35.4K
- EDSA 15.0K
- Earning Date
- NCRA 08-13-2025
- EDSA 08-08-2025
- Dividend Yield
- NCRA N/A
- EDSA N/A
- EPS Growth
- NCRA N/A
- EDSA N/A
- EPS
- NCRA N/A
- EDSA N/A
- Revenue
- NCRA $16,647,379.00
- EDSA N/A
- Revenue This Year
- NCRA N/A
- EDSA N/A
- Revenue Next Year
- NCRA N/A
- EDSA N/A
- P/E Ratio
- NCRA N/A
- EDSA N/A
- Revenue Growth
- NCRA N/A
- EDSA N/A
- 52 Week Low
- NCRA $0.70
- EDSA $1.55
- 52 Week High
- NCRA $2.09
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- NCRA 50.39
- EDSA 55.28
- Support Level
- NCRA $0.96
- EDSA $1.99
- Resistance Level
- NCRA $1.05
- EDSA $2.11
- Average True Range (ATR)
- NCRA 0.06
- EDSA 0.11
- MACD
- NCRA -0.00
- EDSA 0.02
- Stochastic Oscillator
- NCRA 83.33
- EDSA 72.41
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.